FDA & ICH
![](https://www.wcgclinical.com/wp-content/uploads/2024/02/shutterstock_2348563213-edited-scaled.jpg)
FDA & ICH
Sunsetting FDA Enforcement Discretion of Laboratory Developed Tests
Blog Posts![](https://www.wcgclinical.com/wp-content/uploads/2021/02/document-review-desk.jpg)
FDA & ICH
Function over Form: Assessing Different Consent Form Formats
Whitepapers![](https://www.wcgclinical.com/wp-content/uploads/2023/05/shutterstock_1809871564.jpg)
Ethics in Clinical Research
Research and Cannabis: Ethical Research in a Changing Regulatory Landscape
Whitepapers![](https://www.wcgclinical.com/wp-content/uploads/2023/03/shutterstock_1281259918.jpg)
Ethics in Clinical Research
What Can Institutions with Local IRBs Do to Prepare for a Proposed FDA Single IRB Mandate?
Whitepapers![](https://www.wcgclinical.com/wp-content/uploads/2020/07/consultation-meeting.jpg)
Ethics in Clinical Research
Reviewing the FDA’s Proposed Single IRB Mandate
Whitepapers![](https://www.wcgclinical.com/wp-content/uploads/2020/05/doctor-consent-form-elderly-patient.jpg)
Ethics in Clinical Research
Reviewing the FDA’s Proposed Informed Consent Rule Changes
Whitepapers![](https://www.wcgclinical.com/wp-content/uploads/2020/07/itemeditorimage_5d3f40b58fa89.jpg)
Ethics in Clinical Research
Understanding the FDA’s new proposed regulations on human subject research and their impact on your clinical trial plans
Videos![](https://www.wcgclinical.com/wp-content/uploads/2023/06/WCG-generic-visual-concept-12.jpg)
FDA & ICH
Assessing Potential Risks in the Consideration of IND Exemption Criteria
Blog Posts![](https://www.wcgclinical.com/wp-content/uploads/2023/06/WCG-generic-visual-concept-24.jpg)
Ethics in Clinical Research
Defining “Minimal Risk” in Clinical Research
Blog Posts![](https://www.wcgclinical.com/wp-content/uploads/2021/02/document-review-desk.jpg)
Ethics in Clinical Research